Repeated PPV effective for macular holes

Article

Repeated pars plana vitrectomy, with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the Journal of Retinal and Vitreous Diseases.

Repeated pars plana vitrectomy (PPV), with internal limiting membrane peeling and gas tamponade, is a safe and effective treatment technique for persistent macular holes, states an investigation in the journal Retina.

A retrospective study, led by Dr E. Moissesiev, Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, involved 29 eyes that underwent repeated pars plana vitrectomy and limiting membrane peeling. The group obtained demographic information, visual acuity before the first and second operations, MH diameter before and after both surgical procedures and throughout the follow-up. Additional details retrieved included surgical details, time between surgeries, final visual acuity and the occurrence of any complications.

Reoperation caused the closure of persistent MH in 68.9% of the eyes and final visual acuity significantly improved, compared to results from before the second surgery.

In total, 62% of patients gained >2 lines after reoperation, with shorter interoperative time and smaller initial MH diameter significantly correlating with better visual prognosis.

The abstract can be viewed here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.